Details of the Drug

General Information of Drug (ID: DM9MKQ5)

Drug Name
Hu3F8 mAb
Indication
Disease Entry ICD 11 Status REF
Neuroblastoma 2D11.2 Phase 2 [1]
Osteosarcoma 2B51 Phase 2 [2]
Cross-matching ID
TTD ID
D0R4UA
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ganglioside GD2 (GD2) TT80ARU NOUNIPROTAC Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT02502786) Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma.